At a glance
TB-500 is a supply name that requires an exact molecular specification. Fragment and full-length thymosin β4 evidence must be kept separate.
Limits of the evidence. Do not apply full-length thymosin β4 findings to a fragment. An exact sequence or an adequately characterized reference is needed to resolve the identity of a particular supply.
Identity and specifications
An analytical study identified the acetylated seven-residue fragment Ac-LKKTETQ in a product labelled TB-500. Full-length thymosin β4 is a different molecule. That finding cannot identify another supplier’s material.
What the selected studies examined
Esposito and colleagues synthesized and characterized the fragment found in the investigated sample. This was analytical identity research, not a trial demonstrating clinical effects.
Limitations and open questions
Do not apply full-length thymosin β4 findings to a fragment. An exact sequence or an adequately characterized reference is needed to resolve the identity of a particular supply.
These publications describe the materials and experimental conditions used by their authors. They do not establish the identity, composition, stability, safety or performance of East Coast Labs material. A reference list is a selected starting point, not a systematic review.
Interpreting a supplied material
Check the exact product and selected size, then read its documentation status. A laboratory report describes the named sample at the stated date; it does not establish a match to current stock. Read Testing & quality for the distinction between document authenticity and a documented lot relationship.
Handling, solvent compatibility and stability require material-specific information and a validated laboratory protocol. Published biological findings do not establish storage conditions or suitability for a particular experiment.
